Florence Castelli-Golfier

Title: Florence Castelli-Golfier: Innovator in Cancer Immunotherapy

Introduction

Florence Castelli-Golfier is a prominent inventor based in Châtillon, France. She has made significant contributions to the field of cancer immunotherapy through her innovative research and development of immunogenic peptides.

Latest Patents

Florence holds a patent for "Immunogenic peptides of the cyclin B1 tumor antigen." This invention relates to peptides that comprise at least one CD4T epitope, which is immunodominant in vitro. These peptides are capable of stimulating a specific human CD4T lymphocyte response in subjects with varied HLA II molecules. The peptides are intended for use as a cancer vaccine and as a reagent for the diagnosis of cancer or for immunomonitoring the cellular response against cyclin B1 during cancer or anticancer treatment. She has 1 patent to her name.

Career Highlights

Florence is associated with the Commissariat à l'Énergie Atomique et aux Énergies Alternatives, where she continues her research in cancer immunotherapy. Her work has been pivotal in advancing the understanding of tumor antigens and their role in immune response.

Collaborations

Florence collaborates with notable colleagues, including Emmanuel Favry and Anaïs M'Houmadi, who contribute to her research efforts and the development of innovative solutions in cancer treatment.

Conclusion

Florence Castelli-Golfier is a trailblazer in the field of cancer immunotherapy, with her innovative work paving the way for new therapeutic approaches. Her contributions are vital in the ongoing fight against cancer, showcasing the importance of research and innovation in medicine.